Ketamine for the Treatment of Depression in Parkinson's Disease

Clinical trial NCT04944017 · COMPLETED

Trial details

NCT number: NCT04944017
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson's Disease Depression

Start date: 2021-11-23
Primary completion: 2025-09-24
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.